Anika Therapeutics Inc.
22.56 - 23.58
19.95 - 45.81
Join Discuss about ANIK with like-minded investors
Next Dividend Date
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Anika Therapeutics partners with clinicians to understand what they need most to treat their patients and develos minimally invasive products that restore active living for people around the world. The company ise committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe.
CEO: Joseph Darling
HQ: 32 Wiggins Ave Bedford, 01730-2315 Massachusetts